作者： 李智维

作者单位： Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia. Institute for Clinical Medicine, Sechenov University, Moscow, Russia. Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland. Division of Experimental Oncology, Department of Urology, Urological Research Institute, Vita-Salute San Raffaele, Milan, Italy. Department of Urology, James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Department of Urology, Clinico San Carlos University Hospital, Madrid, Spain. Department of Surgery, S.H. Ho Urology Center, The Chinese University of Hong Kong, Hong Kong, China.

归属分类： 膀胱肿瘤治疗及预后证据

DOI： 10.1007/s10147-021-02061-0

关键词： fluorescence in situ hybridization meta-analysis non-muscle invasive bladder cancer surveillance needs to disclose.